<?xml version='1.0' encoding='utf-8'?>
<document id="27186409"><sentence text="Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells."><entity charOffset="51-67" id="DDI-PubMed.27186409.s1.e0" text="N-acetylcysteine" /></sentence><sentence text="Intraperitoneal chemotherapy together with cytoreductive surgery is the standard of care for a number of peritoneal surface malignancies" /><sentence text=" However, this approach fails to maintain the complete response and disease recurs due to microscopic residual disease" /><sentence text=" Although safer than systemic chemotherapy regimens, locoregional treatment with chemotherapeutics can induce toxicity which is a major concern affecting the patient's treatment protocol and outcome" /><sentence text=" For an enhanced treatment efficacy, efforts should be made to maximize cytotoxic effects of chemotherapeutic agents on tumor cells while minimizing their toxic effects on host cells" /><sentence text=" Bromelain and N-acetylcysteine are two natural agents with good safety profiles shown to have anti-cancer effects"><entity charOffset="15-31" id="DDI-PubMed.27186409.s6.e0" text="N-acetylcysteine" /></sentence><sentence text=" However, their interaction with chemotherapeutics is unknown" /><sentence text=" In this study, we investigated if these agents have the potential to sensitize in vitro gastrointestinal cancer models to cisplatin, paclitaxel, 5-fluorouracil, and vincristine"><entity charOffset="123-132" id="DDI-PubMed.27186409.s8.e0" text="cisplatin" /><entity charOffset="134-144" id="DDI-PubMed.27186409.s8.e1" text="paclitaxel" /><entity charOffset="146-160" id="DDI-PubMed.27186409.s8.e2" text="5-fluorouracil" /><entity charOffset="166-177" id="DDI-PubMed.27186409.s8.e3" text="vincristine" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e0" e2="DDI-PubMed.27186409.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e0" e2="DDI-PubMed.27186409.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e0" e2="DDI-PubMed.27186409.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e0" e2="DDI-PubMed.27186409.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e1" e2="DDI-PubMed.27186409.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e1" e2="DDI-PubMed.27186409.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e1" e2="DDI-PubMed.27186409.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e2" e2="DDI-PubMed.27186409.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27186409.s8.e2" e2="DDI-PubMed.27186409.s8.e3" /></sentence><sentence text=" The drug-drug interaction was also analyzed" /><sentence text=" Our findings suggest that combination of bromelain and N-acetylcysteine with chemotherapeutic agents could give rise to an improved chemotherapeutic index in therapeutic approaches to peritoneal surface malignancies of gastrointestinal origin so that maximum benefits could result from less toxic and more patient-friendly doses"><entity charOffset="56-72" id="DDI-PubMed.27186409.s10.e0" text="N-acetylcysteine" /></sentence><sentence text=" This represents a potentially efficacious strategy for the enhancement of microscopic cytoreduction and is a promising area for future research" /><sentence text=" " /></document>